Copper Chaperone Atox1 Interacts with Cell Cycle Proteins by Matson Dzebo, Maria et al.
Copper Chaperone Atox1 Interacts with Cell Cycle Proteins
Downloaded from: https://research.chalmers.se, 2019-05-11 19:38 UTC
Citation for the original published paper (version of record):
Matson Dzebo, M., Blockhuys, S., Valenzuela, S. et al (2018)
Copper Chaperone Atox1 Interacts with Cell Cycle Proteins
Computational and Structural Biotechnology Journal, 16: 443-449
http://dx.doi.org/10.1016/j.csbj.2018.10.018
N.B. When citing this work, cite the original published paper.
research.chalmers.se offers the possibility of retrieving research publications produced at Chalmers University of Technology.
It covers all kind of research output: articles, dissertations, conference papers, reports etc. since 2004.
research.chalmers.se is administrated and maintained by Chalmers Library
(article starts on next page)
Computational and Structural Biotechnology Journal 16 (2018) 443–449
Contents lists available at ScienceDirect
journa l homepage: www.e lsev ie r .com/ locate /csb jCopper Chaperone Atox1 Interacts with Cell Cycle ProteinsMaria Matson Dzebo, Stéphanie Blockhuys, Sebastian Valenzuela, Emanuele Celauro,
Elin K. Esbjörner, Pernilla Wittung-Stafshede ⁎
Department of Biology and Biological Engineering, Chalmers University of Technology, 412 96 Gothenburg, Sweden⁎ Corresponding author.
E-mail address: Pernilla.wittung@chalmers.se (P. Witt
https://doi.org/10.1016/j.csbj.2018.10.018
2001-0370/© 2018 The Authors. Published by Elsevier B.V
NC-ND license (http://creativecommons.org/licenses/by-na b s t r a c ta r t i c l e i n f oArticle history:
Received 13 September 2018
Received in revised form 20 October 2018
Accepted 26 October 2018
Available online 31 October 2018The anaphase-promoting complex (APC) is involved in several processes in the cell cycle, most prominently it fa-
cilitates the separation of the sister chromatids during mitosis, before cell division. Because of the key role in the
cell cycle, APC is suggested as a putative target for anticancer agents. We here show that the copper chaperone
Atox1, known for shuttling copper in the cytoplasm from Ctr1 to ATP7A/B in the secretory pathway, interacts
with several APC subunits. Atox1 interactions with APC subunits were discovered by mass spectrometry of co-
immunoprecipitated samples and further conﬁrmedusingproximity ligation assays inHEK293T cells. Upon com-
paringwild-type cells with those inwhich the Atox1 gene had been knocked out, we found that in the absence of
Atox1 protein, cells have prolonged G2/M phases and a slower proliferation rate. Thus, in addition to copper
transport for loading of copper-dependent enzymes, Atox1 may modulate the cell cycle by interacting with
APC subunits.
© 2018 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural
Biotechnology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Copper (Cu) ions in oxidized and reduced forms are found in the ac-
tive sites of many essential proteins that participate in key cellular reac-
tions often involving electron transfer [1–3]. However, free Cu ions are
potentially toxic for cells since, due to their redox activity, they are capa-
ble of producing reactive oxygen species [4]. To avoid Cu toxicity, the in-
tracellular concentration of Cu is regulated via dedicated proteins that
facilitate uptake, efﬂux as well as distribution of Cu to Cu-dependent
proteins and enzymes [5–7]. In the human cytoplasm, after the uptake
of Cu ions by the membrane-spanning Ctr1 trimer [8], the small Cu
chaperone Atox1 transports the metal to ATP7A and ATP7B (also called
Menke's and Wilson disease proteins, respectively), two homologous
membrane-bound P1B-type ATPases located in the trans-Golgi network.
Once transferred toATP7A/B, theCu ion is channeled to the lumen of the
Golgi where it is loaded onto Cu-dependent proteins and enzymes in
the secretory pathway [9–12].
However, it is becomingmore andmore obvious that the concept of
‘one protein – one function’ is naive.Many proteins appear to havemul-
tiple functions and this has become clear also for Atox1. In 2008, Atox1
was reported to have additional activity in the nucleus as a Cu-
dependent transcription factor (TF) of several genes [13–17]. We alsoung-Stafshede).
. on behalf of Research Network of Co
c-nd/4.0/).conﬁrmed the presence of Atox1 in the nucleus of HeLa cells, but no
DNA binding of Atox1 to the proposed GAAAGA promotor sequence
in vitro was detected [18]. Nonetheless, Atox1 may regulate gene tran-
scription via additional proteins that in turn bind DNA. Using a yeast
two-hybrid screen of a large human fragment library, a number of
new Atox1-interacting proteins were identiﬁed as conﬁdent hits [19].
Among these target proteins, several were reported as detected in the
nucleus and described as DNA/RNA-binding proteins [19]. However,
these experiments were made in yeast and may not necessarily repre-
sent interactions taking place in human cells. In addition, Atox1 was
found to localize at lamellipodia edges in breast cancer cells and, by a
yet unknown mechanism, promote cancer cell migration [20]. Clearly,
Atox1 may have more activities than basic copper transport to the se-
cretory pathway [9,21].
To reveal Atox1 interaction partners in human cells, we here devel-
oped a co-immunoprecipitation protocol for Atox1 in human embryonic
kidney (HEK293T) cells and used it, together with mass spectrometry
analysis, to identify new protein interactions. The results revealed that
several Atox1 interaction partners are subunits of the large multi-
protein anaphase-promoting complex (here abbreviated as APC; also
called cyclosome, or APC/C). APC is a cullin-RING E3 ubiquitin ligase
that facilitates chromatid separation in mitosis before cell division, but
it also has additional cell cycle functions such regulation of cyclins
[22,23]. We direct readers to several excellent reviews for information
on function and mechanism of APC [22,24–26]. Therefore, aftermputational and Structural Biotechnology. This is an open access article under the CC BY-
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imity ligation assay, we used Atox1 knock-out (KO) cells to investigate
the putative role of Atox1 in the cell cycle and proliferation of
HEK293T cells.
2. Materials and Methods
2.1. Cell Culture
HEK293T and MDA-MB-231 cells were purchased from ATCC (Ma-
nassas, VA, USA). The cells were cultured in Dulbecco's modiﬁed Eagle's
medium containing high glucose, pyruvate and L-glutamine (Gibco),
supplemented with 10% fetal bovine serum (Hyclone, GE healthcare),
at 37 °C in a humidiﬁed atmosphere with 5% CO2. Cells were washed
with DPBS without calcium andmagnesium (Gibco) once and detached
using TrypLE express (Gibco) at a conﬂuency of about 80% for sub-
culturing.
2.2. Atox1 KO Cell Line
We used CRISPR-Cas9 technology coupled to LoxP-driven recombi-
nation to establish an Atox1 KO cell line of HEK293T cells. Unlike in
standard knock-out strategies, where the reading frame and the tran-
scription start site are simply disrupted by the insertion of a reporter/se-
lection cassette, we opted for a complete excision of the Atox1 genomic
locus, by knocking in two LoxP sites, ﬂanking the locus itself. To obtain
this, after synchronization for 16 hwith 10mMRo-3306 CDK1 inhibitor
(Sigma Aldrich), HEK293T cells were washed with DPBS without cal-
cium and magnesium (Gibco), detached with Tryple Express
(ThermoFisher) washed again in DPBS and re-suspended in the electro-
poration mix, containing the pre-assembled Cas9(v2)/gRNA ribonu-
cleoprotein (Life Technologies) and the ssDNA template for each LoxP
cassette (Euroﬁns Genomics).
Cells were immediately electroporated using a Neon Transfection
System (ThermoFisher) (pulse voltage 1150 V, pulse width 20 ms, 2
pulses) and a 10 μL tip. The electroporated cells were expanded and ge-
nomic DNA extracted from an aliquot to verify the correct insertion of
each LoxP cassette, ﬂanking the Atox1 locus. Once conﬁrmed both
LoxP cassettes, the addition of Cre recombinase-containing gesicles
(Clontech, Takara) directly to the culture medium allowed the ‘ﬂoxing
out’, i.e. the excision, of the entire Atox1 locus through recognition of
the two oriented LoxP sites. At this stage, the ﬂoxed culture was still a
mix of edited and non-edited cells (Fig. S1) and clonal isolation by serial
dilutionwas performed. Differentmonoclonal lines were expanded and
lack of Atox1 in each was analyzed by immunostainings and Western
blots. Only one of the cell lines showing a complete lack of Atox1, fur-
ther veriﬁed by PCR, was then used for the experiments involving KO
cells. The KO cells were cultured under the same conditions as wild-
type (wt) cells.
Identiﬁcation of Cas9 target sequences for the insertion of the LoxP
cassettes was made with the Dharmacon online tool (http://
dharmacon.gelifesciences.com/gene-editing/crispr-cas9/crispr-design-
tool/). The design of the two sgRNA(−L/R) and the resulting ssDNA
templates, to exploit the homology-directed repair pathway to intro-
duce the LoxP cassettes, was performed with the Dharmacon web tool
(http://dharmacon.horizondiscovery.com/gene-editing/crispr-cas9/
edit-r-hdr-donor-designer-oligo/). Sequences used (5′-3′):
sgRNA-L: ACCACTCACCGGCATGACTG (b)
sgRNA-R: ATGGACCAAAGGGGGCAGGT (N)
LoxP: ATAACTTCGTATAATGTATGCTATACGAAGTTAT (b) - 34 bp
Atox1.LoxP-L ssDNA: GGC GCT GCTGAC ACC GCC GCC ACA CCG CCG
CCA CAC CGC CGC TGC CTC AGA TAA CTT CGT ATA GCA TAC ATT ATA
CGA AGT TAT TCA TGC CGG TGA GTG GTT GCG CCG TCC CCG CCA CGC
AGA CTT GCA GTC CC
Atox1.LoxP-R ssDNA: AGTAGCAGGGGC CTGGTC CCC ACAGCC CAC
AGG ATG GAC CAA AGG GGG CAA TAA CTT CGT ATA GCA TAC ATT ATACGA AGT TAT GGT GGG TAA GGC CCC AGC ACT TGC TGA ACA AAC CTA
CAG CTC ACA CCT CT.
2.3. Lysis of Cells
Cells (80% conﬂuency) were washed with DPBS prior to lysing with
lysis buffer (Pierce IP lysis buffer, Thermo Scientiﬁc) and incubated at 4
°C for 10 min on a rotary shaker. The lysate was centrifuged at 13,000g
for 10 min at 4 °C and the supernatant was used for further studies.
2.4. Co-Immunoprecipitation (Co-IP)
Co-IP was performed with Pierce MS-compatible Magnetic IP Kit
(ThermoFisher) using an adapted protocol. Magnetic beads (50 uL)
were washed 3 times with coupling buffer. 10 μg rabbit anti-Atox1
monoclonal antibody (Abcam) or 10 μg rabbit monoclonal IgG isotype
control antibody (Abcam) in 500 uL coupling buffer (20 mM Na phos-
phate pH 7–9, 150mMNaCl, 0.05% Tween 20)was added to thewashed
beads and the solution was incubated for 15 min at room temperature
(vortexed every 5 min). The antibody-conjugated beads were washed
with coupling buffer three times before incubation with 5 mM
disuccinimidyl suberate (DSS, ThermoFisher) during 45 min at room
temperature on a tube rotator. To quench crosslinking, TRIS buffer (pre-
pared from Trizma-HCl, Sigma Aldrich) was added to a ﬁnal concentra-
tion of 25mMand the beads were incubated on the tube rotator 15min
at room temperature prior to three washes with coupling buffer. The
beads were further blocked with 1× Roti-Block (Carl Roth) for 30 min
at 4 °Cwith rotation and thenmixedwith pre-cleared cell lysate (cell ly-
sate incubated 30 min at 4 °C with magnetic beads, without antibodies,
to avoid non-speciﬁc binding to the beads). The beads were incubated
with the pre-cleared cell lysate during 4 h and then washed with the
wash buffers in the kit according to the manufacturer's recommenda-
tion (5 washes in total). Elution was done with 100 μL elution buffer
during 10 min. Upon Western blot detection of Atox1, the samples
were sent for analysis the Proteomics Core Facility at the Sahlgrenska
Academy, University of Gothenburg.
Eluates from the IP were digested with trypsin usingmodiﬁed ﬁlter-
aided sample preparation (FASP) protocol [27]. Brieﬂy, sodium dodecyl
sulfate (SDS) and triethylammoniumbicarbonate (TEAB)were added to
ﬁnal concentrations of 2% SDS and 50mMTEAB prior to reduction using
100mMdithiothreitol at 60 °C for 30min. Reduced sampleswere trans-
ferred and concentrated onto 10 kDa MWCO Pall Nanosep centrifugal
ﬁlters (Sigma-Aldrich) and washed repeatedly with 8 M Urea. Alkyl-
ation was performed with 10 mM methyl methane thiosulfonate
(MMTS) diluted in digestion buffer (1% sodium deoxycholate (SDC),
50 mM TEAB) for 30 min in room temperature. Trypsin (0.3 μg, Pierce
Trypsin Protease, MS Grade, Thermo Fisher Scientiﬁc) in digestion
buffer was added and the samples were incubated at 37 °C overnight.
Another portion of trypsin (0.3 μg) was added and incubated for an
extra 3 h. Peptides were collected by centrifugation and SDC was re-
moved by acidiﬁcation with 10% triﬂuoroacetic acid. Samples were fur-
ther puriﬁed using Detergent Removal Spin Column (Pierce,
ThermoFischer Scientiﬁc) followed by C18 Desalting Spin Column
(Pierce, ThermoFischer Scientiﬁc) according to the manufacturer's
guidelines. The detergent-free supernatants were dried and
reconstituted in 3% acetonitrile (ACN) in 0.1% formic acid (FA) for LC-
MS analysis.
Peptide samples were analyzed on a QExactive HF mass spectrome-
ter interfaced with Easy-nLC1200 liquid chromatography system
(ThermoFisher Scientiﬁc). Peptides were trapped on an Acclaim
Pepmap 100 C18 trap column (100 μm × 2 cm, particle size 5 μm,
ThermoFischer Scientiﬁc) and separated on an in-house packed analyt-
ical column (75 μm× 300 mm, particle size 3 μm, Reprosil-Pur C18, Dr.
Maisch) using a gradient from 9% to 48% B over 75 min, followed by an
increase to 100% B for 5 min at a ﬂow of 300 nL/min, where Solvent A
was 0.2% FA and solvent B was 80% ACN in 0.2% FA. The instrument
Fig. 1.Western blot detection of Atox1 in co-IP samples: blot. cell lysate (L), ﬂow through
(FT), washes (W1–5) and immunoprecipitates (IP) with an Atox1-antibody as bait aswell
as using an isotype control antibody (IC). See also Fig. S2.
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tra were acquired at a resolution of 60,000, the 10 most intense ions
were isolated in a 1.2 Da isolation window and fragmented using colli-
sion energy HCD settings at 28. MS2 spectra were recorded at a resolu-
tion of 30,000 with charge states 2 to 4 selected for fragmentation and
dynamic exclusion set to 20 s.
Data analysis was performed using Proteome Discoverer version 1.4
(ThermoFisher Scientiﬁc) against the Human Uniprot Database Nov
2017 (Swiss Institute of Bioinformatics, Switzerland). Mascot 2.5 (Ma-
trix Science) was used as a search enginewith precursormass tolerance
of 5 ppm and fragment mass tolerance of 200 millimass units. Tryptic
peptides were accepted with one missed cleavage. Variable modiﬁca-
tion of methionine oxidation and ﬁxed cysteine alkylation were se-
lected. The detected peptide threshold in the software was set to a
signiﬁcance level of Mascot 99% by searching against a reversed data-
base and identiﬁed proteins were grouped by sharing the same se-
quences to minimize redundancy.
2.5. Western Blot Analysis
The proteins were separated with gel electrophoresis, using Novex
Bis-Tris 4–12% gels, MES buffer, NuPAGE LDS loading buffer and
NuPAGE reducing agent according to the manufacturer's recommenda-
tions (ThermoFisher). The proteins were then transferred to a PVDF
membrane using a Trans-Blot Turbo system (1.3 A, 25 V for 7 min)
and the RTA lf-PVDF kit (Bio-Rad) according to the manufacturer's in-
structions. Antibody incubations were performed with Super Signal
West FemtoRabbit orMouse kit (ThermoFisher) alongwith primary an-
tibody incubations overnight: rabbit anti-Atox1 (1 μg/mL, Abcam),
mouse anti-GADPH (2 μg/mL, Abcam), mouse anti-cyclin B1 (1 μg/mL,
Santa Cruz) or mouse anti-cyclin A (1 μg/mL, Santa Cruz), and detected
with ChemiDocMP (Bio-Rad) usinghigh sensitivity chemiluminescence
detection.
2.6. In Situ Proximity Ligation Assay (PLA)
PLA was performed on ﬁxed HEK293T cells using the Duolink® De-
tection Reagents Green kit (Sigma Aldrich) according to the manufac-
turer's instructions. Brieﬂy, HEK293T cells were permeabilized in PBS
+ 0.1% Triton-X-100 for 10 min and washed in PBS. Cells were incu-
bated in blocking solution for 1 h at 37 °C and then with a pair of pri-
mary antibodies of different species mouse anti-Atox1 (0.5 μg/mL,
Abcam), and rabbit anti-APC1 (1 μg/mL, Novus Biologicals), rabbit
anti-APC3 (1 μg/mL, Novus Biologicals), rabbit anti-APC5 (1 μg/mL,
Novus Biologicals), rabbit anti-APC7 (1 μg/mL, Novus Biologicals) rabbit
anti-beta actin (1 μg/mL, Abcam) or rabbit anti-ATP7A (2 μg/mL,
Abcam) overnight at 4 °C. The coverslips were washed in buffer A,
followed by incubation with the PLA probes (secondary antibodies
against two different species bound to two oligonucleotides: anti-
mouse PLUS and anti-rabbit MINUS) for 1 h at 37 °C. Cells were washed
in Buffer A and incubated with ligation solution for 30 min, and ampli-
ﬁcation solution for 100 min, both at 37 °C. The preparations were ﬁ-
nally washed in Buffer B, and mounted with Duolink in situmounting
medium containing DAPI. Z-stack confocal images were collected
through the entire cells at 2 μm interval on an Eclipse Ti 2 inverted mi-
croscope (Nikon), equipped with a Nikon 60X/1.4_S oil immersion ob-
jective. Maximum intensity projections representing approximately
30% of the cell volume were generated, followed by manual setting of
the image threshold at 145–255 to highlight the PLA dots and automatic
counting of the PLA dots using the ‘Analyze particles’ function in Image J
software [28]. In order to represent the number of PLA dots per cell, cell
numbers were manually counted using the in parallel taken bright ﬁeld
images. Quantiﬁcation was performed for two independent PLA exper-
iments, whereby all cells were analyzed within 3 to 5 images per condi-
tion, with an average cell number per image of 25 (SEM ± 1.17) for
HEK293T and 21 (SEM ± 0.90) for HEK293T Atox1 KO. Total cellnumber analyzed was 187, 232, 206 and 162 for Atox1-APC1, Atox1-
APC3, Atox1-APC5 and Atox1-APC7, respectively, in HEK293T cells,
and 174, 174, 103 and 143 for Atox1-APC1, Atox1-APC3, Atox1-APC5
and Atox1-APC7, respectively, in HEK293T Atox1 KO cells. Two-sided,
unpaired t-test was used for statistical analysis.
2.7. Flow Cytometry
Cells werewashedwith PBS and detached using TrypLE express. The
cell pellet was washed with PBS and re-suspended in a small volume of
PBS. The cell suspension was added dropwise to ice-cold 99.7% ethanol
(Solveco) to a ﬁnal ethanol concentration of 70% and kept in−20 °C
overnight.
Wt and Atox1 KO HEK293T cells were incubated in 10% FBS com-
plete medium for 72 h and were ethanol-ﬁxed before reaching 80%
conﬂuency. Cells were then pelleted and resuspended in PBS and
added to a round bottom 96-well plate (Nunc) and an equal volume
of 2× PI staining solution, containing 1:250 propidium iodide
(ThermoFisher) and 1:25 RNase A (ThermoFisher) in PBS, was added.
The cells were incubated 2 h at room temperature and 48 h at 4 °C
prior to analysis with a Guava EasyCyte 8HT ﬂow cytometer (Merck
Millipore).
The red ﬂuorescence of PI was monitored to indirectly examine the
DNA content of the cells. Cells were gated using the area versus width
plot of the red ﬂuorescence (to exclude doublets), and forward and
side scatter. The red ﬂuorescence intensity was analyzed with Guava
InCyte software of three technical replicates. The mean cellular ﬂuores-
cence of three separate experiments was plotted with error bars corre-
sponding to the standard deviation of mean.
2.8. Cell Proliferation Assay
Single cell suspensions were prepared from 80% conﬂuent cell cul-
tures and seeded in 6-well plates (40,000 cells per well). Cells were in-
cubated at 37 °C and 5% CO2 and cell number was measured using an
automatic cell counter (Countess II FL, ThermoFisher Scientiﬁc) at
24 h, 48 h and 72 h after cell seeding. We performed three independent
experiments, and each individual experiment consisted out of 3 rep-
licas. Live/dead cells were probed after 72 h using a commercial kit
(Live/dead viability/cytotoxicity kit, ThermoFisher Scientiﬁc). Two-
sided, paired t-test was used for statistical analysis.
3. Results
3.1. New Atox1 partners identiﬁed with co-immunoprecipitation
To ﬁnd new interaction partners of the Cu chaperoneAtox1 inmam-
malian cells, co-immunoprecipitation (co-IP) experiments were per-
formed in HEK293T cells using antibody-coupled magnetic beads.
Because Atox1 is a small (68 residues) protein, extensive optimization
was required to obtain successful Atox1 immunoprecipitation from
the cell lysate (Fig. 1, Fig. S2). In parallel control experiments, we used
an isotype control antibody coupled to the beads. The co-IP samples
were analyzed by nano-LC MS/MS for the detection of peptide frag-
ments. A Mascot 99 ﬁlter (1% false discovery rate) was used for nano-
LC MS/MS analysis and detection of one unique peptide in the Atox1
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(hit).
Proteins immunoprecipitated with Atox1, but not with the isotype
control, and identiﬁed with at least four unique peptides in the Atox1
sample, are listed in Table 1. Complete lists of identiﬁed proteins (in
Atox1 and control samples) in the HEK293T cells are provided in
Table S1. Surprisingly, upon inspection of the data in Table 1, it is evi-
dent that proteins involved in the cell cycle are the top hits in our exper-
iments. In particular, several anaphase-promoting complex (APC)
subunits are found on top of the list of proteins immunoprecipitated
with Atox1. The hits with the highest number of unique peptides iden-
tiﬁed are in descending order APC1, APC7, APC3 and APC5.
Notably, when the same co-IP experiment was performed in the
cancer cell line MDA-MB-231, we also found APC subunits (including
APC1, APC7, APC3 and APC5 noted above) as the primary proteins
immunoprecipitated with Atox1 (overlap in hits between cell lines are
marked in Table 1). Complete lists of identiﬁed proteins (in Atox1 andTable 1
Proteins co-immunoprecipitated with Atox1 (using antibody-coupled beads) from
HEK293T cells identiﬁed by nano-LC MS/MSa. Bold gene names indicate subunits of the
APC complex’; italic protein description represent proteins (APC subunits and the regula-
tors CDC20 and CDH1) involved in the cell cycle.
Gene
name
Protein description Uniprot
Accession
Number of
unique
peptides
ANAPC1 Anaphase-promoting complex subunit 1b Q9H1A4 28
ANAPC7 Anaphase-promoting complex subunit 7b Q9UJX3 24
ANAPC3
(CDC27)
Anaphase-promoting complex subunitb(Cell
division cycle protein 27 homolog)
P30260 20
ANAPC5 Anaphase-promoting complex subunit 5b Q9UJX4 14
ANAPC8
(CDC23)
Anaphase-promoting complex subunit 8b
(Cell division cycle protein 23 homolog)
Q9UJX2 13
SARNP SAP domain-containing ribonucleoproteinb P82979 11
ANAPC2 Anaphase-promoting complex subunit 2b Q9UJX6 10
ANAPC6
(CDC16)
Anaphase Promoting Complex subunit 6b(Cell
division cycle protein 16 homolog)
Q13042 10
TOMM70 Mitochondrial import receptor subunit
TOM70
O94826 10
ANAPC10 Anaphase-promoting complex subunit 10b Q9UM13 7
ANAPC4 Anaphase-promoting complex subunit 4b Q9UJX5 7
MOGS Mannosyl-oligosaccharide glucosidase Q13724 7
LETMD1 LETM1 domain-containing protein 1 Q6P1Q0 6
NEK2 Serine/threonine-protein kinase Nek2 P51955 6
PARP1 Poly [ADP-ribose] polymerase 1 P09874 6
CDC20 Cell division cycle protein 20 homologb Q12834 5
CDH1
(FZR1)
Fizzy and cell division cycle 20 related 1
(Fizzy-related protein homolog)
Q9UM11 5
NEK1 Serine/threonine-protein kinase Nek1 Q96PY6 5
ALDH3A2 Fatty aldehyde dehydrogenase P51648 4
ANAPC16 Anaphase-promoting complex subunit 16b Q96DE5 4
C3orf58 Deleted in autism protein 1 Q8NDZ4 4
FAR1 Fatty acyl-CoA reductase Q8WVX9 4
TMPO Lamina-associated polypeptide 2, isoforms
beta/gammab
P42167 4
SLC25A11 Mitochondrial 2-oxoglutarate/malate
carrier protein
Q02978 4
MARC2 Mitochondrial amidoxime reducing
component 2
Q969Z3 4
OCIAD1 OCIA domain-containing protein 1 Q9NX40 4
PTGES2 Prostaglandin E synthase 2 Q9H7Z7 4
PHLDB2 Pleckstrin homology-like domain family B
member 2
Q86SQ0 4
RPS16 40S ribosomal protein S16b P62249 4
SEC22B Vesicle-trafﬁcking protein SEC22b O75396 4
VDAC1 Voltage-dependent anion-selective channel
protein 1
P21796 4
XRCC6 X-ray repair cross-complementing protein
6
P12956 4
a The list contains proteins identiﬁedwith at least four unique peptides in theAtox1 co-
IP but no peptide in the isotype control co-IP. A complete list of for both Atox1 and isotype
control co-IP in the HEK293T cells is found in Table S1.
b These proteins were also co-immunoprecipitated with Atox1 in MDA-MB-231 breast
cancer cells, see Table S2 for complete list for this cell line.control samples) in the MDA-MB-231 cells are reported in Table S2.
We note that no known Atox1 partners in the Cu transport chain were
immuno-precipitated in our experiments (e.g., Ctr1, ATP7A/B). This ob-
servation suggests that this experimental approach favors copper-
independent interactions. Therefore, the results obtained here do not
necessarily report on dominant Atox1 interactions but merely identify
APC subunits as being among cellular Atox1 interaction partners.
3.2. Proximity Ligation Assay to Detect Atox1-APC Interactions in Cells
To directly probe Atox1 interactions with APC subunits in the
HEK293T cells, we employed the recently developed proximity liga-
tion assay (PLA) which exhibits single-molecule resolution [29,30].
Here, oligonucleotide probes are attached to antibodies against two
proteins of interest and, if they are bound in close proximity (b
40 nm), the oligonucleotides guide the formation of circular DNA
strands. The DNA circles can then serve as templates for localized
rolling-circle ampliﬁcation which allows pairs of protein molecules
in close proximity to be visualized and counted in situ using ﬂuores-
cence microscopy. As a negative control for the PLA experiments,
and also used in our other experiments (see below), we created an
Atox1 KO cell line of the HEK293T cells (Fig. S1).
We used PLA to assess Atox1 interactions in situ for APC1, APC3,
APC5 and APC7. The subunits APC1, APC3 and APC7 were selected as
they are the top three hits in the immunoprecipitation results in
HEK293T cells; APC5 was chosen as it is located further away from
APC1, APC3 and APC7 in the structure of the complete APC complex
[22,23] but still is among the top four hits in Table 1. Quantitative anal-
ysis of the results for Atox1 and APC1, APC3 and APC7, respectively,
showed higher number of dots in each case as compared to the back-
ground found in the KO cell line (Fig. 2), indicating close proximity be-
tween Atox1 and APC1, APC3 and APC7 in the HEK293T cells. However,
for APC5, no speciﬁc Atox1 interaction was found using PLA, indicating
that this APC subunit is not in close proximity of Atox1 and, therefore,
likely interacts indirectly with Atox1 via other APC subunits. Notably,
the PLA data demonstrates that the interactions between Atox1 and
APCs take place in the cytoplasm (Fig. 2). Several control experiments
were performed to assess the accuracy of the PLA results. As positive
and negative controls we performed PLA for Atox1-ATP7A and Atox1-
beta actin interactions, respectively, in wt and Atox1 KO HEK293T
cells. We also conﬁrmed the speciﬁcity of the anti-Atox1 antibody by a
PLA experiment for Atox1 detection using anti-mouse minus and plus
PLA probes in wt and Atox1 KOHEK293T cells (Fig. S3). The PLA results,
together with the co-IP results, encouraged us to further study a possi-
ble role of Atox1 in the cell cycle.
3.3. Consequence for Cells of Atox1 Knock out (KO)
The cell cycle can be divided into interphase (including G1, S, and G2
stages) followed by mitosis (M phase, which includes the anaphase)
and cytokinesis, with the last two steps facilitating cell division. Ana-
phase starts when cytoplasmic APC labels an inhibitory chaperone
with ubiquitin [22,23] resulting in a cascade of events that promotes sis-
ter chromatid separation. Activator subunits target APC to speciﬁc sets
of substrates at different times in the cell cycle: Cdc20 activates inmito-
sis and Cdh1 activates in interphase [26]. Atox1 may modulate APC ac-
tivity at any stage of the cell cycle, as both Cdc20 and Cdh1 were
found in the Atox1 co-IP (Table 1).
To probe if Atox1-APC interactions have an effect on cell cycle pro-
gression, we ﬁrst compared the cell cycle distribution of wt and Atox1
KO (Fig. S1) HEK293T cells using ﬂow cytometry. We found that the
cell cycle distribution was altered for the KO line: Whereas the wt
cells are found to be mostly in G1 and S phases, the KO cells have an in-
creased population of the G2/M phases and decreased population of the
S phase (Fig. 3, Fig. S4A). Normally, the mammalian cell cycle takes
about 20 h, with half of the time being spent in G1 phase. The G2/M
Fig. 2.A. Representative confocal maximum intensity projection images of the in situ proximity ligation assay (PLA) between (a) Atox1 andAPC1, (b) Atox1 and APC3, (c) Atox1 and APC5,
and (d) Atox1 and APC7 in thewt and Atox1 KOHEK293T cells (upper and lower panel, respectively). A positive PLA signal appears as a green dot. Cell nuclei are stained with DAPI (blue
color). Scale bars indicate 10 μm. B. Quantitative analysis of the PLA signals using the confocal images in ImageJ software. Results are shown as mean ± SEM. Statistical signiﬁcance is
indicated as follows: *p b 0.05, **p b 0.01, ***p b 0.001 (using the two-sided, unpaired t-test). (For interpretation of the references to color in this ﬁgure legend, the reader is referred
to the web version of this article.)
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spent in the S phase. Inspection of the fractions of cells in different
phases for the two cell types shows that the fraction of total cell cycle
time the cells spend in G2/M phases has increased from about 23% to
33% when Atox1 is absent (Fig. 3A). As another evidence of altered
cell cycle phases, we compared the amounts of cyclins A and B1 in
wt and Atox1 KO cells. Both these cyclins are accumulated in G2/M
phases [31] and, in accord with the ﬂow cytometry data, we ﬁnd a
trend of increased cyclins A and B1 in the KO cells (Fig. S4B). Unfortu-
nately, the differences were not statistically signiﬁcant which may be
due to the rather small increase in G2/M percentage for the KO cells.
Taken together, removing Atox1 protein from the cells prolongs the
duration of G2/M phases compared to G1 and S, resulting in G2/M
enrichment.
That knock out of Atox1 in cells results in slower growth than corre-
sponding wt cells has been reported for mouse embryonic ﬁbroblasts
[14]. To link altered cell cycle stage distribution to cell growth of our
cells, we probed cell proliferation of wt and Atox1 KO HEK293T cells
over 72 h (Fig. 3B). The data shows that the Atox1 KO cells proliferate
slower than thewt cells: at 72 h the amount of wt cells is almost double
that of the KO cells. To test if the result was due to slower proliferation
or increased cell death, we probed the presence of dead cells in both wt
and KO cells after 72 h of growth. Data from Live/Dead staining experi-
ments showed that the number of dead cells was low in both cell lines
(b2%; data not shown).Fig. 3.A.Cell cycle distribution ofwt andAtox1KOHEK293T cells by PI staining andﬂowcytome
with G2/M DNA content was increased for the KO cells (p b 0.01). The error bars are standar
measurement of total cell number at 24 h, 48 h and 72 h after seeding (40.000 cells/well at t
Standard error indicates standard error of the mean, and * indicates p b 0.001 with two-sidedTaken together, removal of Atox1 from the cells increases the popu-
lation of cells in G2/M phases and slows down overall cell proliferation.
A tentative explanation for these observations is that Atox1 is a co-
activator of APC, helping it to advance through later stages of the cell
cycle, thereby facilitating proliferation.
4. Discussion
We here show that the copper chaperone Atox1, known for
transporting Cu in the cytoplasm, interacts with subunits in the
anaphase-promoting complex (APC). APC is a 1.2 MDa complex includ-
ing 19 APC subunits and coactivators that regulatesmultiple steps in the
cell cycle, but most prominently, mitosis [22,23]. High resolution struc-
tures of the multi-protein APC complex, with different coactivators
bound, have been resolved by cryo-electron microscopy [23,32]. From
the deduced arrangement of subunits in the APC complex, the here dis-
covered subunits co-immunoprecipitated with Atox1 can be located to
two regions. The top three hits in Table 1 are APC1, APC7 and APC3;
these proteins are located near each other on one side of the complex
(right side, Fig. 4) and are also closely connected to APC10, APC16 and
modulator Cdh1 proteins, also on list in Table 1. The fourth and ﬁfth
top hits in Table 1, APC5 and APC8, are located next to each other on
the other side of the APC complex (left side, Fig. 4) and are connected
to APC2, APC6 and APC4 (also in Table 1). Using in situ proximity liga-
tion directly in cells, we conﬁrmed Atox1 interactions (close proximity)
for APC1, APC3 and APC7 (top three hits in Table 1) but not for APC5.try analysis. Thepercent cells in S phasewasdecreased (pb 0.01)whereas the amount cells
d deviation of mean (n = 3). B. Cell proliferation of wt and Atox1 KO HEK293T cells by
ime zero). Decreased proliferation rate for Atox1 KO in comparison to wt HEK293T cells.
t-test (3 independent experiments with three replicas in each).
Fig. 4. Structure of anaphase-promoting complex (APC) with the subunits, identiﬁed in
the co-IP-MS with at least 4 unique peptides, in color. Subunits APC11, APC13, APC15,
and F-box only protein 5 were not found in the analysis of the Atox1 co-IP using nano-
LC MS/MS and are shown in grey; also in grey is APC12 which was identiﬁed in the
Atox1 immunoprecipitation experiment with only 2 unique peptides. The subunits
identiﬁed with largest number of unique peptides are all located in the same area, APC7
(red), APC1 (cyan) and APC3 (light green, also called CDC27). Image made using PDB ID
4UI9 [23] and UCSF Chimera 1.11.2 software [37]. (For interpretation of the references
to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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by APC1, APC3 and APC7 which, as the APC complex is a stable multi-
domain structure, results in co-immunoprecipitation of almost all APC
subunits. Thus, APC5 and several other of the APC subunits listed in
Table 1 are not interacting directly with Atox1 but are co-
immunoprecipitated due to their presence in the APC complex.
Although it remains unclear how/if Atox1 binding affects the activity
of the APC complex, we found that removal of Atox1 protein from the
HEK293T cells enriches cells in the G2/M phases and, in parallel, slows
down their proliferation rate. Thus, we speculate that Atox1 acts as an
activator that upon binding aids APC with progression through later
stages of cell division. However, as Atox1 has additional functions in cel-
lular copper metabolism, a direct link between Atox1 interaction with
APC and functional effects on the cell cycle and proliferation cannot be
made. Additional biochemical and cell biology studies are needed to
conﬁrm this idea.
Nonetheless, there are some interesting associations to benoted. In a
related study, the global transcriptional response to deletion of the yeast
Atox1 homolog gene, Atx1, in Saccharomyces cerevisiae was analyzed
and the results indicated a possible role of Atx1 in cell cycle related pro-
cesses in yeast [33]. It was found that several transcripts for proteins re-
lated with the meiotic cell cycle and its transcriptional regulation were
repressed upon deletion of the Atox1 gene irrespective of the copper
level [33]. For mammals, it was proposed that Atox1 was a copper-
dependent transcription factor that mediated cell proliferation. It was
shown that copper stimulation of mouse embryonic ﬁbroblasts mark-
edly increased cell proliferation, cyclin D1 expression, and entry into S
phase; processes which all were completely abolished in Atox1 KO
cells [14]. Although there were no biophysical support for Atox1 being
a DNA-binding protein directly regulating the cyclin D1 promoter [18],
these ﬁndings may be interpreted in light of our current results. Cyclin
D1 is the main regulator of the cyclin-dependent kinase CDK4 in the
G1 phase and it was shown that, during the metaphase to anaphase
transition, APC degrades CDK4 and cyclin D1 is sequestered in the cyto-
plasm [34]. CDK4 re-accumulates in the following G1 phase and facili-
tates nuclear import of cyclin D1 [34]; thus without CDK4, cyclin D1
cannot promote S phase. Therefore, we speculate that the reported rela-
tionship between Atox1 and Cyclin D1 may involve dysfunction of APC
(due to the absence of Atox1) affecting degradation of CDK4 that, in
turn, affects cyclin D1 function. Atox1 has also been identiﬁed to beimportant for proliferation of non-small lung cancer cells and it was
even proposed that Atox1 may be a potential therapeutic target for
lung cancer therapy [35].
The effects of altered copper levels and/or importance of Atox1being
copper-loaded for the here observed cell cycle effects and APC interac-
tions should be speciﬁcally addressed in future work. A recent study in-
dicated that small synthetic molecules, blocking the copper-binding
ability of Atox1 and of another cytoplasmic copper chaperone, resulted
in inhibition of proliferation of cancer cells and thesemolecules also sig-
niﬁcantly attenuated tumor growth in xenograft mice models [36].
These effects were proposed to be due to accumulation of free copper
ions in cells that caused oxidative damage and killed the cells [36].
Based on our results, part of the noted changes may be due to cell
cycle/growth defects due to an abolished Atox1 network of interactions.
In conclusion, we have discovered that the copper chaperone Atox1
interacts with subunits of APC, which is a complex involved in several
steps of the cell cycle. Further studies are required to reveal the molec-
ular mechanisms of this interaction and its consequences for the cell
cycle. Such studies are of importance as they may reveal new targets
for the development of anticancer drugs and, from a fundamental
point of view, they may also identify a connection between copper me-
tabolism and the cell cycle.
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